Miri Halperin Wernli
Equibles does not estimate personal net worth.
About Miri Halperin Wernli
Earlier roles on record: Board Member at Definium Therapeutics, Inc. (DFTX) until August 11, 2022. Definium Therapeutics, Inc. reported in an 8-K filed January 13, 2025 that Miri Halperin Wernli was terminated as Executive President, effective February 28, 2025. Definium Therapeutics, Inc. reported in an 8-K filed August 11, 2022 that Miri Halperin Wernli resigned as Director, effective August 11, 2022. The proxy statement of Definium Therapeutics, Inc. reports total compensation of $2,663,528 for Miri Halperin Wernli in fiscal 2021, including a base salary of $377,464. Disclosed compensation is on record for 2 fiscal years.
“On January 10, 2025, Mind Medicine (MindMed) Inc. (the "Company") notified Miri Halperin Wernli, the Company's Executive President, that it was terminating her employment without cause, effective February 28, 2025, as the Company centralizes its management team in the United States to enhance collaboration and alignment with its strategic goals.”
“On August 11, 2022, Miri Halperin Wernli, M.D. notified the Board of Directors (the "Board") of Mind Medicine (MindMed) Inc. (the "Company") that she is resigning from the Board as of August 11, 2022.”
Affiliation history
-
Definium Therapeutics, Inc. (DFTX)
Proxy statement
Start not stated–2025-02-28
-
Start not stated–2022-08-11
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Definium Therapeutics, Inc. (DFTX) | Executive President | $377,464 | $2,663,528 |
| 2020 | Definium Therapeutics, Inc. (DFTX) | Executive President | $131,292 | $996,147 |